BMI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now: price trend is still decisively bearish (SMA_200 > SMA_20 > SMA_5) and the stock is trading below the key pivot (157.589), suggesting rallies are likely to be sold.", "No Intellectia edge today: there is no AI Stock Picker or SwingMax buy trigger to justify an impatient entry.", "Near-term setup is only a potential oversold bounce, not a confirmed reversal; with insiders aggressively selling and analysts cutting targets, risk/reward is not favorable for an immediate buy.", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: no signal on given stock today.\n- SwingMax: No signal on given stock recently."]
["Trend: Bearish (SMA_200 > SMA_20 > SMA_5), consistent with a multi-week downtrend after the post-earnings drop.", "Momentum: MACD histogram -2.258 (below 0) but negatively contracting, indicating downside momentum is easing, yet still bearish.", "RSI_6: 31.143, near oversold conditions\u2014supports the idea of a short-term bounce attempt, but not a trend reversal by itself.", "Key levels: Support S1 143.895 (price 146.5 pre-market is close\u2014critical line in the sand), deeper support S2 135.434; resistance/pivot 157.589, then R1 171.284."]
["Fundamentals remain solid in the latest quarter with revenue/EPS and margins up YoY, supporting the long-term story.", "News/Street commentary highlights potential 2H 2026 re-acceleration expectations and increased visibility for a second-half inflection (per multiple analysts).", "RBC notes a major AMI contract win (Puerto Rico) that can support future deployments and backlog confidence."]
["Post-earnings narrative is still negative: Q4 sales miss and muted near-term outlook drove a sharp drawdown, keeping sentiment fragile.", "Insiders are selling aggressively (selling amount up 911.83% over the last month), which is a strong near-term confidence headwind.", "Analyst targets were broadly cut, and Argus downgraded to Hold, reinforcing the perception of decelerating growth and valuation/risk concerns.", "Technical structure remains weak; a break below 143.895 raises risk of a move toward 135.434."]
["Latest quarter: 2025/Q4", "Revenue: $220.706M, +7.57% YoY (growth positive but came in below some expectations per news/analyst notes).", "Net income: $33.575M, +9.30% YoY.", "EPS: $1.14, +9.62% YoY.", "Gross margin: 42.13%, up 4.46% YoY, indicating operational improvement even with topline volatility."]
["Recent trend: broad price-target cuts across the Street after Q4 results (e.g., Stifel 215\u2192166, Baird 205\u2192165, DB 185\u2192167, RBC 229\u2192191, Seaport 255\u2192220, Barclays 157\u2192136).", "Rating mix: still some bullish stances (RBC Outperform, Stifel Buy, Seaport Buy, JPM Overweight; Jefferies Buy), but caution increased with Argus downgrade to Hold and Barclays Underweight.", "Wall Street pros: AMI cycle \u201cstill has legs,\u201d margin strength, large contract wins, potential 2H 2026 rebound.", "Wall Street cons: near-term growth deceleration fears, Q4 sales miss reinforcing bear case, valuation/setup concerns, and a more muted early-2026 outlook."]
